Morgan Stanley’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$28.5M Sell
1,520,217
-16,770
-1% -$314K ﹤0.01% 2459
2025
Q1
$27.7M Sell
1,536,987
-24,509
-2% -$441K ﹤0.01% 2355
2024
Q4
$26.3M Buy
1,561,496
+97,997
+7% +$1.65M ﹤0.01% 2490
2024
Q3
$23.7M Buy
1,463,499
+38,643
+3% +$625K ﹤0.01% 2634
2024
Q2
$11.7M Sell
1,424,856
-19,230
-1% -$158K ﹤0.01% 3196
2024
Q1
$21.4M Sell
1,444,086
-1,446,937
-50% -$21.4M ﹤0.01% 2620
2023
Q4
$41.9M Buy
2,891,023
+2,192,775
+314% +$31.8M ﹤0.01% 2641
2023
Q3
$7.54M Buy
698,248
+311,816
+81% +$3.37M ﹤0.01% 3380
2023
Q2
$4.98M Buy
386,432
+336,451
+673% +$4.34M ﹤0.01% 3781
2023
Q1
$660K Sell
49,981
-10,512
-17% -$139K ﹤0.01% 5099
2022
Q4
$907K Sell
60,493
-29,764
-33% -$446K ﹤0.01% 4925
2022
Q3
$1.06M Sell
90,257
-128,641
-59% -$1.52M ﹤0.01% 4846
2022
Q2
$2.47M Buy
218,898
+105,248
+93% +$1.19M ﹤0.01% 4367
2022
Q1
$3.4M Buy
113,650
+26,859
+31% +$803K ﹤0.01% 4076
2021
Q4
$2.3M Sell
86,791
-19,513
-18% -$517K ﹤0.01% 4465
2021
Q3
$3.86M Sell
106,304
-34,048
-24% -$1.24M ﹤0.01% 3989
2021
Q2
$6.09M Buy
140,352
+2,094
+2% +$90.9K ﹤0.01% 3579
2021
Q1
$4.73M Sell
138,258
-384,272
-74% -$13.1M ﹤0.01% 3478
2020
Q4
$18.3M Buy
522,530
+232,959
+80% +$8.15M ﹤0.01% 1889
2020
Q3
$6.95M Buy
289,571
+153,318
+113% +$3.68M ﹤0.01% 2383
2020
Q2
$2.49M Sell
136,253
-114,905
-46% -$2.1M ﹤0.01% 3380
2020
Q1
$3.92M Buy
251,158
+140,554
+127% +$2.19M ﹤0.01% 2684
2019
Q4
$2.37M Buy
110,604
+102,385
+1,246% +$2.19M ﹤0.01% 3903
2019
Q3
$154K Sell
8,219
-4,989
-38% -$93.5K ﹤0.01% 5263
2019
Q2
$344K Sell
13,208
-174,901
-93% -$4.56M ﹤0.01% 4786
2019
Q1
$4.84M Sell
188,109
-94,163
-33% -$2.42M ﹤0.01% 2757
2018
Q4
$6.49M Buy
282,272
+11,263
+4% +$259K ﹤0.01% 2584
2018
Q3
$8.7M Buy
271,009
+126,072
+87% +$4.05M ﹤0.01% 2553
2018
Q2
$4.1M Buy
144,937
+74,793
+107% +$2.12M ﹤0.01% 3374
2018
Q1
$2.48M Buy
70,144
+39,161
+126% +$1.39M ﹤0.01% 3776
2017
Q4
$1.2M Buy
30,983
+13,045
+73% +$506K ﹤0.01% 4421
2017
Q3
$456K Sell
17,938
-2,718
-13% -$69.1K ﹤0.01% 4935
2017
Q2
$563K Sell
20,656
-9,393
-31% -$256K ﹤0.01% 4726
2017
Q1
$994K Sell
30,049
-38,954
-56% -$1.29M ﹤0.01% 4385
2016
Q4
$1.64M Buy
69,003
+64,080
+1,302% +$1.52M ﹤0.01% 4092
2016
Q3
$181K Sell
4,923
-555
-10% -$20.4K ﹤0.01% 5064
2016
Q2
$122K Sell
5,478
-5,744
-51% -$128K ﹤0.01% 5161
2016
Q1
$234K Sell
11,222
-11,546
-51% -$241K ﹤0.01% 4889
2015
Q4
$690K Buy
22,768
+8,828
+63% +$268K ﹤0.01% 4320
2015
Q3
$344K Sell
13,940
-3,915
-22% -$96.6K ﹤0.01% 4813
2015
Q2
$573K Buy
17,855
+9,783
+121% +$314K ﹤0.01% 4621
2015
Q1
$288K Sell
8,072
-4,022
-33% -$144K ﹤0.01% 5003
2014
Q4
$275K Sell
12,094
-4,076
-25% -$92.7K ﹤0.01% 5056
2014
Q3
$313K Sell
16,170
-130,948
-89% -$2.53M ﹤0.01% 4878
2014
Q2
$5.34M Sell
147,118
-4,383
-3% -$159K ﹤0.01% 2617
2014
Q1
$5.88M Sell
151,501
-6,911
-4% -$268K ﹤0.01% 2434
2013
Q4
$4.51M Buy
158,412
+20,393
+15% +$581K ﹤0.01% 2667
2013
Q3
$4.94M Buy
138,019
+134,469
+3,788% +$4.81M ﹤0.01% 2426
2013
Q2
$118K Buy
+3,550
New +$118K ﹤0.01% 5034